Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)-Reference-Cited by-同舟云学术

Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)

Published:2016-04 Issue:2 Volume:14 Page:e153-e159
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Bamias Aristotle,Peroukidis Stavros,Stamatopoulou Sophia,Tzannis Kimon,Koutsoukos Konstantinos^ORCID,Andreadis Charalambos,Bozionelou Vasiliki,Pistalmatzian Nikos,Papatsoris Athanasios,Stravodimos Konstantinos,Varthalitis Ioannis,Karamouzis Michalis,Milaki Georgia,Agorastos Antonios,Kentepozidis Nikos,Androulakis Nikos,Bompolaki Iliada,Kalofonos Haralampos,Mavroudis Dimitrios,Dimopoulos Meletios A.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference22 articles.

1. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s;Karim-Kos;Eur J Cancer,2008

2. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for transitional cell carcinoma of the urothelium;Sternberg;J Urol,1985

3. M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for advanced transitional cell carcinoma of the urothelium;Sternberg;J Urol,1988

4. Long-term follow-up of a phase III Intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a Cooperative Group Study;Saxman;J Clin Oncol,1997

5. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;Von der Maase;J Clin Oncol,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics, Treatment Delivery, and Cisplatin Eligibility in Korean Patients Initially Diagnosed with Urothelial Carcinoma;The Ewha Medical Journal;2021-07-31

2. Comparative Study of the Safety and Efficacy of First-Line Cisplatin and Carboplatin Chemotherapy in Elderly Patients with Metastatic Urothelial Carcinoma;Oncology;2019-12-03

3. The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer;The Oncologist;2019-04-01

4. Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece––the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG);Expert Review of Pharmacoeconomics & Outcomes Research;2018-11-19

5. Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC);Annals of Oncology;2018-02